Nice Insight Reports
Biotech Funding Ups and Downs
April Stanley, MS MBA
Nice Insight
PAO-04-24-NI-01Apr 02, 2024
FDA New Drug Approvals
Many First-in-Class Drugs Approved by FDA in 2022, but Overall Approval Numbers Down
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-03-23-NI-03Mar 07, 2023
Cell and Gene Therapy
State of the Cell and Gene Therapy Market
James Grote
Nice Insight
PAO-10-022-NI-01Oct 11, 2022